SM
ELV icon

SG3 Management’s Elevance Health ELV Stock Holding History

SG3 Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$746K – 1110
2021
Q3 		$746K Buy
2,000
+250
+14% +$95K 0.02% 524
2021
Q2 		$668K Buy
1,750
+430
+33% +$164K 0.02% 586
2021
Q1 		$474K Hold
1,320
– – 0.01% 790
2020
Q4 		$424K Buy
+1,320
New +$405K 0.01% 763
2019
Q3 		– Sell
-9,000
Closed -$2.47M – 363
2019
Q2 		$2.54M Buy
+9,000
New +$2.46M 0.28% 75

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

SG3 Management's ELV Position: Q4 2021 in Review

SG3 Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 2,000 shares — an estimated $746K sold.

SG3 Management first reported a position in ELV in Q2 2019 and held it in 5 quarters. The position peaked at $2.54M in Q2 2019. 1,373 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • SG3 Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • SG3 Management sold 2,000 Elevance Health shares in Q4 2021, an estimated $746K.
  • SG3 Management first reported a position in Elevance Health in Q2 2019 and held it in 5 quarters.
  • SG3 Management's Elevance Health position peaked at $2.54M in Q2 2019.
  • 1,373 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.